THE DUBERSTEIN GROUP INC.

Lobbying for GILEAD SCIENCES, INC. · Biotechnology company that researches, develops and commercializes drugs.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $90,000.00 income · posted Oct 20, 2025

Lobbying activity 2

Health Issues

HIV Funding

Trade (domestic/foreign)

Issues related to trade

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.